Author

K. Burk

Observed name: K Burk

Observed institutions: Cleveland Clinic, The Royal Free Hospital, University Medical Center Freiburg, Institut Gustave Roussy, Centre Léon Bérard, Royal Marsden Hospital, The Christie Hospital, The Christie NHS Foundation Trust, Addenbrooke's Hospital, Bayer (Germany)

OpenAlex ID: A5113331833

Randomized phase II trial of first-line treatment with sorafenib versus interferon in patients with advanced renal cell carcinoma: Final results

2007 · C. Szczylik, T. Demkow, et al. · Journal of Clinical Oncology · 135

Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma

2006 · C. Bolling, T. Graefe, et al. · Investigational New Drugs · 78

Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion

1998 · I. Rassmann, R. Thödtmann, et al. · Investigational New Drugs · 33

Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans

1990 · K. Mross, U. Mayer, et al. · European Journal of Clinical Pharmacology · 27

Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH

1996 · K. Mross, A. Hüttmann, et al. · Cancer Chemotherapy and Pharmacology · 21

Phase II trial of sorafenib combined with dacarbazine in metastatic melanoma patients

2006 · P. Lorigan, P. Corrie, et al. · Journal of Clinical Oncology · 20

Phase I Clinical Trial of Lobaplatin (D-19466) after Intravenous Bolus Injection

2009 · H.H. Fiebig, H. Henß, et al. · Onkologie · 19

High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study

1990 · A. Harstrick, H.-J. Schmoll, et al. · Annals of Oncology · 17

Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.

1989 · K Burk, K H Kurth, et al. · PubMed · 9

Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors

1992 · K. Mross, K. Hamm, et al. · Cancer Chemotherapy and Pharmacology · 8

Miltefosine Solution: Prognostic Factors for the Outcome of Topical Treatment of Skin Meta-static Breast Cancer

2009 · H. Sindermann, K. Junge, et al. · Onkologie · 6

lobaplatin in combination with methotrexate and vinblastine in patients with transitional cell carcinoma of the urinary tract—a pilot phase I/(II) study

1995 · P. Jung, P. Bachmann, et al. · European Journal of Cancer · 5

Jodo-Doxorubicin, ein neues Anthrazyklin-Derivat

2009 · K.B. Mross, T. Langenbuch, et al. · Onkologie · 4

Weekly epirubicin in patients with hormone refractory prostatic cancer--a two-year follow-up.

1989 · K Burk, W Schultze-Seemann, et al. · PubMed · 4

111 Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK 611 using an oral daily administration schedule

1995 · I. Raßmann, T. Schilling, et al. · European Journal of Cancer · 2

Intravesical idarubicin ? a phase-l study

1994 · W. Schultze-Seemann, K. Burk, et al. · Urological Research · 2

Weekly chemotherapeutic regimen in metastatic prostate cancer.

1989 · K Burk · PubMed · 2

Phase I Study with Iodo-Doxorubicin

1989 · K. Mross, T. Langenbuch, et al. · Beiträge zur Onkologie/Contributions to oncology · 2

Chemotherapy of hormone-resistant carcinoma of the prostate: 4-epi-rubicin weekly v.s. DMF monthly.

1987 · K Burk, C Sropp, et al. · PubMed · 2

Pharmacokinetic results of a phase I trial of sorafenib (S) in combination with dacarbazine (DTIC) in patients with advanced metastatic melanoma or other solid tumors

2007 · E. Brendel, E. Zafarana, et al. · Journal of Clinical Oncology · 1

98 POSTER A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors

2006 · A. Awada, T. Gil, et al. · European Journal of Cancer Supplements · 1

Phase II-Studie zur Behandlung des vorbehandelten, fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC) mit Sorafenib (BAY 43–9006)

2006 · A Lange, U Gatzemeier, et al. · Pneumologie · 1

Tur vs TUR plus adriamycin in patients with superficial bladder cancer--a five-year follow-up.

1989 · K Burk, W Schultze-Seemann, et al. · PubMed · 1

Hinweise für Autoren – Instructions to Authors

2009 · G. Maschmeyer, W. Hiddemann, et al. · Onkologie

Mitteilungen Onkologischer Gesellschaften – Reports Of Oncological Societies

2009 · G. Maschmeyer, W. Hiddemann, et al. · Onkologie

Works count: 39

Citation count: 400

H-index: 9

I10-index: 8